Ticker
PYXSCompany Name
PYXIS ONCOLOGY INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Net Income Common Stock | Return on Assets |
---|---|---|---|
6/30/2025 | $ 123.22M | $ -96.29M | -78.14% |
3/31/2025 | $ 135.87M | $ -95.23M | -70.09% |
12/31/2024 | $ 157.18M | $ -77.33M | -49.2% |
9/30/2024 | $ 195.31M | $ -57.36M | -29.37% |
6/30/2024 | $ 208.39M | $ -59.2M | -28.41% |
3/31/2024 | $ 220.22M | $ -57.8M | -26.25% |
12/31/2023 | $ 173.73M | $ -73.79M | -42.47% |
9/30/2023 | $ 186.69M | $ -94.29M | -50.51% |
6/30/2023 | $ 175.23M | $ -98.92M | -56.45% |
3/31/2023 | $ 182.8M | $ -108.58M | -59.4% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Assets
(=) ROA
ROA for PYXIS ONCOLOGY INC is calculated as follows: Net Inc. Cmn. [ $ -12.83M ] / Assets [ $ 10.15M ]
(=) ROA [ -126.37% ]
Minimum
Dec 31, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.44K |
---|---|
min | -33.4% |
max | 33.98% |
average | 0.12% |
median | 1.53% |
std | 10.61% |